Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-04-30

Clinical Trial Update: Inhaled Nitric Oxide in Brain Injury [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating inhaled nitric oxide for traumatic brain injury has completed, and the trial results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Inhaled nitric oxide (nitric oxide)

Snippet

Sponsor: University of Cincinnati | Conditions: Traumatic Brain Injury | Phase 3 | Status: COMPLETED | Results posted: 2025-04-30